Biopharmaceutical Tubing Market Analysis Report by 2021, 2028

report image

Biopharmaceutical Tubing Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Type (Plastic, Metal, and Silicone) and Application (Pharmaceutical {Single Use Technology, and Others, Medical Devices, Research and Development, and Others)

Publication Month: Feb 2022 | Report Code: TIPRE00008648 | No. of Pages: 174 | Category: Medical Device | Status: Published

The biopharmaceutical tubing market is projected to reach US$ 6,013.27 million by 2028 from US$ 3,442.82 million in 2021; it is expected to grow at a CAGR of 8.3% from 2021 to 2028.  

Biopharmaceutical tubing are specifically designed to meet critical needs of biopharmaceutical and medical industries. This tubing is produced by the extrusion process and is extensively used in drug delivery systems, feeding tubes, and peristaltic pumps as well in a wide range of minimally critical invasive applications, including stent delivery systems, cardiovascular catheters, and urological retrieval devices. Moreover, these are also used with anesthesiology and respiratory equipment, IVs, and biopharmaceutical laboratory equipment. They confer exceptional thermal, mechanical, and chemical properties.

Strategic Insights

Report Coverage - Biopharmaceutical Tubing Market
Report CoverageDetails
Market Size Value inUS$ 3,442.82 Million in 2021
Market Size Value byUS$ 6,013.27 Million by 2028
Growth rateCAGR of 8.3% from 2021-2028
Forecast Period2021-2028
Base Year2021
No. of Pages174
No. of Tables86
No. of Charts & Figures70
Historical data availableYes
Segments coveredType and Application
Regional scopeNorth America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country scopeUS, Canada, Mexico, UK, Germany, Spain, Italy, France, India, China, Japan, South Korea, Australia, UAE, Saudi Arabia, South Africa, Brazil, Argentina
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Free Sample Copy Available


The biopharmaceutical tubing market is segmented on the bases of type, application, and geography. By geography, the market is broadly segmented into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. The report offers insights and in-depth analysis of the market, emphasizing on parameters such as market trends, technological advancements, and market dynamics along with the analysis of competitive landscape of world’s leading market players.            

Lucrative Regions for Biopharmaceutical Tubing Market

Lucrative Regions for Biopharmaceutical Tubing Market

Get more information on this report :


Market Insights

Increasing Elderly Population Drives Biopharmaceutical Tubing Market Growth

Increase in life expectancy is leading to rise in geriatric population in the world. According to the World Health Organization (WHO), the global population share of people with age more than 60 would nearly double from 12% in 2015 to 22% in 2050. According to the United Nation’s World Population Ageing 2017 report, in 2017, there were 962 million people with age 60 or above in the world, and the number is expected to reach ~2.1 billion by 2050. In addition, according to the US Census Bureau, the number of people in the US with age 65 and above is anticipated to grow from 46 million in 2016 to more than 98 million by 2060, their population share would grow from ~15% to ~24% during this period. According to the United Nation’s World Population Ageing 2017 report, in 2017, Europe had the highest percentage of people of age more than 60, i.e., 25%. By 2050, ~25% or more population in all regions of the world, except Africa, would be of age 60 and above. The geriatric population in the world is anticipated to reach US$ 1.4 billion, US$ 2.1 billion, and above US$ 3.1 billion by 2030, 2050, and 2100, respectively.

This rise in the elderly population has led to an increase in the geriatric ailments, thus generating a greater demand for diagnostic equipment and drug delivery systems. It is also resulting in the spike in incidence of urological conditions that require catheterization. Medical professionals are also encouraging self-catheterization to reduce the cost and period of hospitalization as well as to avert the risk of healthcare-associated infections (HAI). Aging is also a main factor that contributes to the surge in the incidence of chronic diseases that might lead to the need for interventions that require admission to ICUs. Thus, rapid growth in the geriatric population is directly proportional to the rising demand for medical devices that incorporate tubing, drug delivery, dialysis and cardiac bypass, peristaltic pump, and sterile filling and dispensing systems, thereby driving the adoption of biopharmaceutical tubing systems.

Rising Demand for Minimally Invasive Procedures Contributes Significantly to Market Growth

A minimally invasive medical procedure is generally carried out by inserting a small device or an implant in body through an incision or anatomical opening. The popularity of these procedures has increased in the recent years due to the involvement of tiny incisions, faster recovery of patients, and less discomfort caused to the patients. Moreover, these procedures are also associated with benefits such as less trauma to muscles, nerves, tissues, and organs; less bleeding and scarring; and minimal injuries to tissues and less pain.

The growing prevalence of arthritis, cancer, and cardiovascular diseases, all of which require extensive surgical treatments, has boosted demand for minimally invasive procedures. As a result, there is an enormous demand for catheters and biopharmaceutical tubing, among other components. Furthermore, biopharmaceutical tubing systems are reasonably priced and aid in time-saving procedures. For example, employing catheter tubing for cardiac and urine catheterization significantly lowers the time required for the medical or surgical operation. Therefore, the growing demand for minimally invasive medical procedures and focus on increasing the efficiency of these procedures play an important role in propelling the demand for biopharmaceutical tubing.

Type Insights                   

Based on type, the global biopharmaceutical tubing market is segmented into plastic, metal, and silicone. In 2020, the silicone segment held the largest share of the market. Moreover, the market for the silicone segment is expected to grow at the highest CAGR during 2021–2028. The biocompatibility of silicone allows it to be compatible with human tissues and body fluids, increasing its use in medical tubing. In addition to biocompatibility, high temperature and chemical resistance, mechanical strength, and electric properties are among the properties that make it a material of choice in biological applications.   

Application Insights

Based on application, the biopharmaceutical tubing market is segmented into pharmaceutical, medical devices, research and development, and others. The pharmaceutical segment is sub segmented as single use technology and others. The pharmaceutical segment held the largest market share in 2020, and it is further expected to be the largest shareholder in the market by 2028. Liquid transfer is an essential part of pharmaceutical manufacturing processes, including the manufacturing of cough syrup and complex active pharmaceutical ingredients (APIs) such as vaccines or specific medications for cancer treatment, and the transfer process must be carried out in a highly regulated environment. Thus, with the growing emphasis on proper transfer tubing systems with escalating production capacities, the pharmaceutical industries demand ultra-pure and corrosion-resistant systems for liquid transfer that withstand harsh environment of chemicals, which is bolstering the market growth of this segment.

Biopharmaceutical Tubing Market, by Type – 2021 and 2028

Biopharmaceutical Tubing Market, by Type – 2021 and 2028

Get more information on this report :


Product launches, and mergers and acquisitions are the highly adopted strategies by the players operating in the global biopharmaceutical tubing market. A few of the recent key product developments are listed below:

In September 2021, DuPont introduced DuPont Liveo, a new brand name for its extensive range of silicone healthcare solutions. The Liveo brand product line includes pharmaceutical tubing and overmolded assemblies for single-use systems in biopharma processing, transdermal and topical drug delivery systems, and medical adhesives, among others.

In June 2020, Nordson acquired Fluortek, a plastic extrusion manufacturer that provides custom dimensioned tubing to the medical device industry. As Nordson Medical continues to expand its diversified product offerings, the acquisition enhances company's ability to deliver critical components for medical device innovations.

The COVID-19 pandemic is having the mixed impact on the biopharmaceutical tubing market. Growing COVID-19 infection in people with existing medical conditions such as asthma and diabetes also influences the growth of the market. There is a rise in the demand for drug delivery devices and equipment such as nasogastric tubes, nebulizers, spacer devices, etc. Therefore, these factors are driving the demand for biopharmaceutical tubing during the forecast period. On the other hand, many countries have changed medical device regulations owing to supply chain obstruction affect negatively on biopharmaceutical tubing market.

Biopharmaceutical Tubing – Market Segmentation

By Type

  • Silicone
  • Plastic
  • Metal

By Application

  • Pharmaceutical
    • Single Use Technology
    • Others
  • Medical Devices
  • Research and Development
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
    • Rest of Middle East & Africa
  • South and Central America (SCAM)
    • Brazil
    • Argentina
    • Rest of South and Central America

Company Profiles

  • W. L. Gore and Associates, Inc.
  • Saint-Gobain Sekurit
  • Freudenberg Group
  • RAUMEDIC AG
  • TEKNI-PLEX
  • NewAge Industries, Inc.
  • Optinova
  • Zeus Industrial Products, Inc.
  • NORDSON CORPORATION
  • DuPont de Nemours, Inc.
  • Specialty Silicone Products, Inc.
  • Hoshine Silicon Industry Co., Ltd.
  • Wacker Chemie AG
  • Shin-Etsu Chemical Co., Ltd.
  • Momentive
  • Elkem ASA
  • Wacker Chemie AG

Frequently Asked Questions

The factors such as increasing elderly population in world and rising demand for minimally invasive procedures drive the market growth. However, the stringent regulatory framework hinders the market growth.
The biopharmaceutical tubing market majorly consists of the players such W. L. Gore and Associates, Inc., Saint-Gobain Sekurit, Freudenberg Group, RAUMEDIC AG, TEKNI-PLEX, NewAge Industries, Inc., Optinova, Zeus Industrial Products, Inc., NORDSON CORPORATION, DuPont de Nemours, Inc., Specialty Silicone Products, Inc., Hoshine Silicon Industry Co., Ltd., Wacker Chemie AG, Shin-Etsu Chemical Co., Ltd., Momentive, Elkem ASA, Wacker Chemie AG among others.
Biopharmaceutical tubing is specifically designed to meet critical needs of biopharmaceutical and medical industries. Biopharmaceutical tubing is produced by the extrusion process and is extensively used in drug delivery systems, feeding tubes, and peristaltic pumps. These offer exceptional thermal, mechanical, and chemical properties used in a wide range of minimally critical invasive applications, including stent delivery systems, cardiovascular catheters, and urological retrieval devices. Moreover, these are also used with anesthesiology and respiratory equipment, IVs, and biopharmaceutical laboratory equipment.
Use of platinum-cured silicone as material of choice for biopharmaceutical tubing is likely to act as a trend the market growth in the coming years.
Silicone segment is growing in the biopharmaceutical tubing market.
Proliferation of healthcare sector and rise in prevalence of chronic diseases in developing countries is likely to fuel the market growth in the coming years.
Asia-Pacific is lucrative for the biopharmaceutical tubing market.

The List of Companies - Biopharmaceutical Tubing Market

  1. W. L. Gore and Associates, Inc.
  2. Saint-Gobain Sekurit
  3. Freudenberg Group
  4. RAUMEDIC AG
  5. TEKNI-PLEX
  6. NewAge Industries, Inc.
  7. Optinova
  8. Zeus Industrial Products, Inc.
  9. NORDSON CORPORATION
  10. DuPont de Nemours, Inc.
  11. Specialty Silicone Products, Inc.
  12. Hoshine Silicon Industry Co., Ltd.
  13. Wacker Chemie AG
  14. Shin-Etsu Chemical Co., Ltd.
  15. Momentive
  16. Elkem ASA
  17. Wacker Chemie AG   
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the biopharmaceutical tubing market. 
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global biopharmaceutical tubing market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
TIPRE00008648
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Get the Latest COVID-19 Analysis on this market




christmas_festive_offer

Have a Question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Speak to Analyst
Pricing
  • $3000 $2700
  • $4550 $4095
  • $6550 $5568
  • $8550 $6840

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

    Inquire for Discount